PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner
Giusy Di Conza1, Sarah Trusso Cafarello1, Xingnan Zheng2
1Laboratory of Tumor Inflammation and Angiogenesis, Vesalius Research Center, VIB, 3000 Leuven, Belgium; Laboratory of Tumor Inflammation and Angiogenesis, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.
Abstract:
B55α is a regulatory subunit of the PP2A phosphatase. We have recently found that B55α-associated PP2A promotes partial deactivation of the HIF-prolyl-hydroxylase enzyme PHD2. Here, we show that, in turn, PHD2 triggers degradation of B55α by hydroxylating it at proline 319. In the context of glucose starvation, PHD2 reduces B55α protein levels, which correlates with MDA-MB231 and MCF7 breast cancer cell death. Under these conditions, PHD2 silencing rescues B55α degradation, overcoming apoptosis, whereas in SKBR3 breast cancer cells showing resistance to glucose starvation, B55α knockdown restores cell death and prevents neoplastic growth in vitro. Treatment of MDA-MB231-derived xenografts with the glucose competitor 2-deoxy-glucose leads to tumor regression in the presence of PHD2. Knockdown of PHD2 induces B55α accumulation and treatment resistance by preventing cell apoptosis. Overall, our data unravel B55α as a PHD2 substrate and highlight a role for PHD2-B55α in the response to nutrient deprivation.
Insights
The enzyme PHD2 triggers the degradation of B55α, a protein crucial for cell survival during glucose starvation. This interaction impacts breast cancer cell death and tumor growth, revealing a new therapeutic target.
Area of Science:
- Cellular Biology
- Biochemistry
- Oncology
Background:
- B55α is a regulatory subunit of Protein Phosphatase 2A (PP2A).
- PP2A associated with B55α partially deactivates the enzyme PHD2 (HIF-prolyl-hydroxylase).
Purpose of the Study:
- To investigate the regulatory relationship between PHD2 and B55α.
- To elucidate the role of the PHD2-B55α interaction in cellular response to nutrient deprivation and cancer progression.
Main Methods:
- In vitro cell culture experiments using breast cancer cell lines (MDA-MB231, MCF7, SKBR3).
- Analysis of protein degradation and hydroxylation.
- Gene silencing (knockdown) of PHD2 and B55α.
- In vivo xenograft studies in mice.
Main Results:
- PHD2 directly hydroxylates B55α at proline 319, targeting it for degradation.
- Glucose starvation induces PHD2-mediated B55α degradation, leading to apoptosis in sensitive breast cancer cells.
- PHD2 silencing prevents B55α degradation, promoting cell survival and treatment resistance.
- B55α knockdown in resistant cells restores sensitivity to glucose starvation and inhibits tumor growth.
- In vivo, 2-deoxy-glucose treatment inhibits tumor growth, dependent on PHD2 activity.
Conclusions:
- B55α is a novel substrate of PHD2, linking nutrient deprivation to protein stability.
- The PHD2-B55α axis plays a critical role in regulating cell fate under metabolic stress.
- Targeting this pathway offers potential therapeutic strategies for breast cancer treatment.
More Related Videos
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cell Specific Gene Expression


